# Kyverna (KYTX) — News

KYTX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/kytx/news

## Recent headlines

- [Bain Capital provides EUR 130M facility for Life Couriers deal](https://www.ainvest.com/news/bain-capital-eur-130m-facility-life-couriers-deal-2610) — AInvest Wire, Oct 14, 2026
  Bain Capital has provided a EUR 130 million financing facility to support the acquisition of Life Couriers, a logistics and delivery services company. The transaction marks another strategic move by the private equity firm in the life sciences and healthcare sectors, where focused its investments…
- [Kyverna Therapeutics: Phase 3 KYSA-6 trial enrollment expected to be completed in mid-2027](https://www.ainvest.com/news/kyverna-therapeutics-phase-3-kysa-6-trial-enrollment-expected-completed-mid-2027-2609) — AInvest Wire, Sep 24, 2026
- [Kyverna Therapeutics: MIV-CEL well-tolerated in GMG trial with no high-grade CRS, ICANS, or IEC-HS](https://www.ainvest.com/news/kyverna-therapeutics-miv-cel-tolerated-gmg-trial-high-grade-crs-icans-iec-hs-2609) — AInvest Wire, Sep 24, 2026
- [Kyverna's MIV-CEL meets all SPS trial endpoints at 12 months](https://www.ainvest.com/news/kyverna-miv-cel-meets-sps-trial-endpoints-12-months-2609) — AInvest Wire, Sep 24, 2026
- [Kyverna Therapeutics reports positive one-year data demonstrating durable clinical responses and favorable safety profile for miv-cel in stiff person syndrome and generalized myasthenia gravis](https://www.ainvest.com/news/kyverna-therapeutics-reports-positive-year-data-demonstrating-durable-clinical-responses-favorable-safety-profile-miv-cel-stiff-person-syndrome-generalized-myasthenia-gravis-2609) — AInvest Wire, Sep 24, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).